Open-label assessment of the long-term tolerability, safety, and efficacy of sertindole in patients with schizophrenia

被引：0
|
作者：
Hale, T. [1 ]
Murray, R. M. [1 ]
Azorin, J. M. [1 ]
Maehlum, E. [1 ]
机构：
[1] St Martins Hosp, Canterbury, Kent, England
来源：
SCHIZOPHRENIA BULLETIN | 2007年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：431 / 432
页数：2
相关论文
共 50 条
  • [41] Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study
    Nakao Iwata
    Jun Ishigooka
    Ichiro Naoi
    Masahiro Matsumoto
    Yuichi Kanamori
    Hiroshi Nakamura
    Teruhiko Higuchi
    CNS Drugs, 2020, 34 : 103 - 116
  • [42] Long-term safety and efficacy of open-label dupilumab in patients with moderate-to-severe atopic dermatitis
    Deleuran, M.
    Thaci, D.
    Beck, L.
    Forman, S.
    Soong, W.
    Hussain, I.
    Bissonnette, R.
    Bouaziz, J.
    Gelfand, J.
    Lawrence, S.
    Chen, Z.
    Akinlade, B.
    Gadkari, A.
    Eckert, L.
    Graham, N.
    Ardeleanu, M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 34 - 34
  • [43] LONG-TERM SAFETY AND TOLERABILITY OF BREXPIPRAZOLE IN PATIENTS WITH SCHIZOPHRENIA
    Hakala, Mika
    Gislum, Mette
    Skuban, Aleksandar
    Meehan, Stine
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S94 - S95
  • [44] Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study
    Iwata, Nakao
    Ishigooka, Jun
    Naoi, Ichiro
    Matsumoto, Masahiro
    Kanamori, Yuichi
    Nakamura, Hiroshi
    Higuchi, Teruhiko
    CNS DRUGS, 2020, 34 (01) : 103 - 116
  • [45] Long-Term Safety, Tolerability and Efficacy of Flexible-Dose Fesoterodine in Elderly Patients With Overactive Bladder: Open-Label Extension of the SOFIA Trial
    Wagg, Adrian
    Khullar, Vik
    Michel, Martin C.
    Oelke, Matthias
    Darekar, Amanda
    Bitoun, Caty Ebel
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (01) : 106 - 114
  • [46] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
    Gevaert, Philippe
    Saenz, Rebecca
    Corren, Jonathan
    Han, Joseph K.
    Mullol, Joaquim
    Lee, Stella E.
    Ow, Randall A.
    Zhao, Rui
    Howard, Monet
    Wong, Kit
    Islam, Lutaf
    Ligueros-Saylan, Monica
    Omachi, Theodore A.
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +
  • [47] A long-term open-label safety study of galcanezumab in Japanese patients with migraine
    Hirata, Koichi
    Takeshima, Takao
    Sakai, Fumihiko
    Tatsuoka, Yoshihisa
    Suzuki, Norihiro
    Igarashi, Hisaka
    Nakamura, Tomomi
    Ozeki, Akichika
    Yamazaki, Hiroyoshi
    Skljarevski, Vladimir
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 721 - 733
  • [48] Assessment of the long-term efficacy and safety of adjunctive perampanel: pooled analyses of four open-label extension studies
    Rektor, Ivan
    Krauss, Gregory L.
    Inoue, Yushi
    Kaneko, Sunao
    Williams, Betsy
    Patten, Anna
    Bibbiani, Francesco
    Laurenza, Antonio
    Wechsler, Robert T.
    NEUROLOGY, 2017, 88
  • [49] Long-term safety and effectiveness of brexpiprazole in Japanese patients with schizophrenia: A 52-week, open-label study
    Ishigooka, Jun
    Iwashita, Shuichi
    Tadori, Yoshihiro
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2018, 72 (06) : 445 - 453
  • [50] Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study
    Ivy, Dunbar
    Beghetti, Maurice
    Juaneda-Simian, Ernesto
    Ravindranath, Ramiya
    Lukas, Mary Ann
    Machlitt-Northen, Sandra
    Scott, Nicola
    Narita, Jun
    Berger, Rolf M. F.
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (05) : 2123 - 2130
12345